2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Squamous Cell Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Cyclophosphamide
3155
Cisplatin
3151
Carboplatin
2929
Paclitaxel
2671
Radiotherapy
2643
Gemcitabine
2544
pembrolizumab
2324
Docetaxel
2154
Bevacizumab
2126
Fluorouracil
1819
Capecitabine
1780
Oxaliplatin
1709
Dexamethasone
1589
Nivolumab
1516
Doxorubicin
1477
Rituximab
1453
Etoposide
1341
Magnetic Resonance Spectroscopy
1261
Irinotecan
1232
Leucovorin
1212
Cytarabine
1123
Pemetrexed
1060
Drug Therapy
1060
fludarabine
1044
Vincristine
956
Specimen Handling
928
Prednisone
924
Cetuximab
919
Lenalidomide
916
Trastuzumab
897
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Metabolic Networks and Pathways
×
Clear all
NCT03307941
2017-12-19
ARTEMIS-Eso
Jules Bordet Institute
Phase 1/2
Withdrawn